GeneReach Biotechnology Corp. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 1,017.56 million compared to TWD 859.22 million a year ago.

Revenue was TWD 1,012.08 million compared to TWD 857.03 million a year ago. Net income was TWD 376.62 million compared to TWD 257.28 million a year ago. Basic earnings per share from continuing operations was TWD 8.1909 compared to TWD 5.6 a year ago.

Diluted earnings per share from continuing operations was TWD 8.0455 compared to TWD 5.5909 a year ago.